Liver disease & HCC

Liver cancer in Japan: Dr Shun Kaneko on HCC screening and surveillance

Liver cancer in Japan: Dr Shun Kaneko on HCC screening and surveillance

Japan is a global leader in hepatocellular carcinoma (HCC) surveillance, with an effective programme that enables early-stage carcinomas detection leading to positive patient outcomes (62% of HCC patients are diagnosed at stage A and B [1] leading to 5-year overall survival rates as high as 44%). Japan’s medical care, health policy and health insurance offerings […]

Liver cancer in Japan: Dr Shun Kaneko on HCC screening and surveillance Read More »

HCC in Thailand: Dr Terachai Songkiatkawin on improving liver cancer diagnostics and treatment

Songkiatkawin_Terachai

In 2020, data from Globocan showed that more than 27,000 patients in Thailand are found to have liver cancer each year, making it the most-frequently diagnosed cancer in the country [1]. Due to gaps in surveillance, diagnostic and treatment services, many patients only discover their condition at advanced stages when the only available option is

HCC in Thailand: Dr Terachai Songkiatkawin on improving liver cancer diagnostics and treatment Read More »

HCV elimination in Northern Pakistan: Prof Aamir Khan on treating patients in KPK province and the Afghan borderlands

HCV elimination in Northern Pakistan: Prof Aamir Khan on treating patients in KPK province and the Afghan borderlands

This article is part of a series on hepatitis C (HCV) elimination in Pakistan and other high-risk countries around the world. Forthcoming articles in this series will cover the Pakistani provinces of Sindh and Punjab. Scroll to the bottom of the article for the full list. Khyber Pakhtunkhwa province, or KPK, is situated in the

HCV elimination in Northern Pakistan: Prof Aamir Khan on treating patients in KPK province and the Afghan borderlands Read More »

Liver disease in Asia Pacific: insights from Prof Pierce Chow

Liver disease in Asia Pacific: Q&A with Prof Pierce Chow

In this Q&A, Prof Pierce Chow of the National Cancer Centre Singapore discusses the epidemiology of liver disease in Asia Pacific; key considerations around the clinical management of common liver diseases like HBV, HCV, fatty liver and HCC; and the critical role of diagnostics in ensuring early detection and effective treatment. [00:09] – Prof Chow’s

Liver disease in Asia Pacific: insights from Prof Pierce Chow Read More »

HCV screening in Egypt: key elements of a successful national screening programme

HCV screening in Egypt: key elements of a successful national screening programme

This article is part of a series on hepatitis C (HCV) elimination in Pakistan and other high-risk countries around the world. Forthcoming articles in this series will cover the Pakistani provinces of Sindh and Punjab. Scroll to the bottom of the article for the full list. Hepatitis C virus (HCV) infection is one of the world’s

HCV screening in Egypt: key elements of a successful national screening programme Read More »

Hepatitis C: the patient journey from screening to diagnosis and treatment

Hepatitis C: the patient journey from screening to diagnosis and treatment

An estimated 71 million people around the world are chronically infected with hepatitis C virus (HCV). Marginalised populations, and particularly people who inject drugs, have low testing and treatment rates for HCV. Several models of care and service delivery interventions have the potential to improve outcomes, but much of the relevant research was carried out when interferon-based treatment

Hepatitis C: the patient journey from screening to diagnosis and treatment Read More »

Scroll to Top